Could starting HIV drugs at birth lead to a 'Functional Cure' for babies?
NCT ID NCT02369406
Summary
This study is testing if starting powerful HIV medication within the first week of life can limit how much of the virus takes hold in a baby's body. The goal is to see if this early treatment could allow children to safely take breaks from medication in the future without the virus quickly returning. The trial involves 67 HIV-positive infants in Botswana and compares them to children who started treatment later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Botswana Harvard HIV/AIDS Institute Partnership
Gaborone, Botswana
Conditions
Explore the condition pages connected to this study.